Filing Flows › Liquidia (LQDA) › Recalls, complaints & regulation
Liquidia (LQDA): clinical trials
Liquidia (LQDA) beyond its filings: 6 active clinical trials.
Liquidia's latest quarter
Liquidia, Q2 2026: revenue $172M (19× year over year), operating margin 49.8%, net earnings $74.7M, operating cash flow $80.2M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Liquidia have?
6 active studies on ClinicalTrials.gov, 3 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.